Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Growth hormone secretion stimulants claimed by Merck & Co.

Nov. 1, 1996

Pulmonary-delivered insulin advances through clinical trials

Nov. 1, 1996

Lilly reports long-acting, soluble insulin analogues

Nov. 1, 1996

Hypoglycemic agents disclosed by Yamanouchi

Nov. 1, 1996

Sheffield Medical Technologies and Alpha Therapeutic enter into option agreement

Nov. 1, 1996

Oncogene awarded drug discovery grant

Nov. 1, 1996

Lilly and Neurocrine collaborate in the areas of obesity and Alzheimer's disease

Nov. 1, 1996

Antiobesity proteins described by Lilly

Nov. 1, 1996

CRADA opportunity for the treatment of atherosclerosis and LCAT deficiency

Nov. 1, 1996

Mitsubishi to copromote OrthoLogic 1000 in Japan

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...